Insider · CIK 0001619298
Versant Ventures V, LLC
Files at TSBX (Turnstone Biologics Corp.). First filing -, latest -.
In brief
Versant Ventures V, LLC files SEC Form 4 as 10% owner at TSBX (Turnstone Biologics Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Versant Ventures V, LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Venture Capital V, L.P. | -2,726,322 | - | - | 0 | Aug 12, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Venture Capital V (Canada) LP | -207,486 | - | - | 0 | Aug 12, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Ophthalmic Affiliates Fund I, L.P. | -90,888 | - | - | 0 | Aug 12, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Affiliates Fund V, L.P. | -82,006 | - | - | 0 | Aug 12, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Vantage II, L.P. | -274,990 | - | - | 0 | Aug 12, 2025 |
Questions about Versant Ventures V, LLC
Answered from the filings on this page, as of the latest one.
Is Versant Ventures V, LLC buying or selling?
Versant Ventures V, LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Versant Ventures V, LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Versant Ventures V, LLC has 0.
Where does Versant Ventures V, LLC file Form 4?
Versant Ventures V, LLC has filed Form 4 at TSBX (Turnstone Biologics Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.